Bain Linda 4
4 · Codiak BioSciences, Inc. · Filed Feb 18, 2022
Insider Transaction Report
Form 4
Bain Linda
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-16+20,300→ 20,300 totalExercise: $5.21Exp: 2032-02-15→ Common Stock (20,300 underlying) - Award
Restricted Stock Units
2022-02-16+30,450→ 30,450 total→ Common Stock (30,450 underlying)
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on February 16, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]On February 16, 2022, the reporting person was granted 30,450 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.